Voluntary workplace genomic testing: wellness benefit or Pandora’s box?
By Kunal Sanghavi, Betty Cohn, Anya E. R. Prince, W. Gregory Feero, Kerry A. Ryan, Kayte Spector-Bagdady, Wendy R. Uhlmann, Charles Lee, J. Scott Roberts & Debra J. H. Mathews,
npj Genomic Medicine
| 01. 20. 2022
Consumer interest in genetic and genomic testing is growing rapidly, with more than 26 million Americans having purchased direct-to-consumer (DTC) genetic testing services1. The global consumer genetic testing market is anticipated to exceed $2.5 billion by 20251,2,3,4. Capitalizing on the increasing comfort of consumers with genetic testing outside the clinical environment, commercial vendors are expanding their customer bases by marketing genetic and genomic testing services, including testing for pharmacogenomic and pathogenic variants, to employers for inclusion in workplace wellness programs. For the purposes of this paper, voluntary workplace genomic testing (wGT) refers to both genetic and genomic testing offered by vendors through voluntary workplace wellness programs, as the full range of testing offered through such programs has not been robustly studied to date. Workplace wellness programs commonly include features like health risk assessments, biometric testing and screening, smoking cessation programs, and gym and health-club memberships5. We describe the potential appeal of wGT to employers and employees, how the ethical, legal, and social implications (ELSI) literature has approached the...
Related Articles
By Jonathan D. Grinstein, Genetic Engineering & Biotechnology News | 06.26.2024
Partial screenshot from The Bridge Recombination Mechanism
video by The Arc Institute on YouTube (CC)
Buried in a family of mobile genetic elements, Arc Institute researchers led by Patrick Hsu, PhD, have discovered an RNA-guided system that enables modular...
By Carl Zimmer, The New York Times | 05.31.2024
Last year, Jaume Pellicer led a team of fellow scientists into a forest on Grande Terre, an island east of Australia. They were in search of a fern called Tmesipteris oblanceolata. Standing just a few inches tall, it was not...
By Liz Szabo, The New York Times | 05.29.2024
By the time Rena Barrow-Wells gave birth to her fourth baby in 2020, she was well-versed in caring for a child with cystic fibrosis. She was also experienced in fighting for a diagnosis of the disease, which runs in families...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...